Samil Pharmaceutical Co Ltd
000520
Company Profile
Business description
Samil Pharmaceutical Co Ltd is engaged in the manufacture and sale of pharmaceuticals and quasi-drugs and related businesses, and its main products and goods include Polybutin, Gliptide, Brufen, Ribact, and Hiabaks.
Contact
155 Hyoryeong-ro
Bangbae-dong, Samil Pharmaceutical Building
Seocho-Gu
Seoul
KORT: +82 25200300
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
598
Stocks News & Analysis
stocks
The best way to get rich and retire early
This goes through the different options including shares, property and business ownership and declares a winner, as well as outlining the mindset needed to earn enough to never have to work again.
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,000.70 | 41.30 | 0.46% |
| CAC 40 | 8,103.62 | 47.76 | -0.59% |
| DAX 40 | 24,209.94 | 78.46 | -0.32% |
| Dow JONES (US) | 48,257.63 | 122.74 | 0.25% |
| FTSE 100 | 9,841.49 | 55.93 | -0.57% |
| HKSE | 25,801.77 | 111.24 | 0.43% |
| NASDAQ | 23,450.66 | 143.04 | 0.61% |
| Nikkei 225 | 50,402.39 | 895.18 | 1.81% |
| NZX 50 Index | 13,508.30 | 174.90 | 1.31% |
| S&P 500 | 6,868.03 | 33.53 | 0.49% |
| S&P/ASX 200 | 8,699.90 | 39.70 | 0.46% |
| SSE Composite Index | 3,917.36 | 26.92 | 0.69% |